Profil
Mr. Peter A. Coleman is a Chief Executive Officer at Roslin Cell Therapies Ltd., a Chief Executive Officer & Director at Cobra Biologics Ltd. and a Secretary & Finance Director at Cobra Biologics Holdings Ltd. He is on the Board of Directors at Cobra Biologics Ltd. Mr. Coleman was previously employed as a Chief Executive Officer & Director by Cobra Biologics Holding AB.
Postes actifs de Peter Coleman
| Sociétés | Poste | Début |
|---|---|---|
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Directeur Financier/CFO | 14/05/2009 |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in development of DNA-based technologies, services and products | Directeur Général | 01/05/2011 |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Directeur Général | 01/03/2022 |
Anciens postes connus de Peter Coleman
| Sociétés | Poste | Fin |
|---|---|---|
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in development of DNA-based technologies, services and products | Health Technology |
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Health Technology |
















